Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Danske Hypotek AB: Year-end report 2019

Year in briefJanuary – December 2019 (the comparison in brackets refers to 2018)· Operating profit was SEK 965 million (717 million) · Net interest income amounted to SEK 1 050 million (825 million) · Costs comprised SEK 101 million (61 million) · Credit losses remained low and amounted to SEK 47 million (SEK -2 million) · Return on equity was 16.9 % (18.4 %) · The CET1 capital ratio was 16.7% (16.1%) · Danske Hypotek’s covered bonds have the highest credit rating (AAA) from Standard & Poor’s Read the full year-end report at https://danskehypotek.se/financial-

Shareholders' proposals to the Annual General Meeting for the remuneration of Kesko's Board of Directors

Kesko Corporation's shareholders jointly holding 15% of the votes attached to the Company’s shares have made a proposal to the Annual General Meeting to be held on 30 March 2020 regarding the remuneration of Board members and the reimbursement of their expenses.Proposal for the remuneration of Board members and the reimbursement of their expenses Kesko Corporation's shareholders jointly holding 15% of the votes attached to the Company’s shares have proposed that the fees for Kesko Corporation’s Board members remain at their current level. The proposal for remuneration and the

Annual report 2019 – Delivered best-in-class results and record high order intake

Vestas Wind Systems A/S, Aarhus, 5 February 2020Company announcement No. 01/2020   Annual report 2019 – Delivered best-in-class results and record high order intake Summary: For full year 2019, revenue amounted to EUR 12.1bn, the EBIT margin before special items was 8.3 percent, and total investments* were EUR 729m, all in line with the expectations. Compared to 2018, revenue and earnings increased while free cash flow decreased. Order intake increased in 2019 compared to 2018, and the value of the combined order backlog increased to EUR 34bn.   The wind turbine order intake

Interim Report Q3 1 April - 31 December 2019

Third quarter (1 October - 31 December 2019) · Net sales increased by 12 percent and amounted to SEK 2,846 million (2,551). · Operating profit before amortisation of intangible non-current assets (EBITA) decreased by 4 percent and amounted to SEK 236 million (246) corresponding to an EBITA margin of 8.3 percent (9.7). · Operating profit decreased by 7 percent and amounted to SEK 188 million (203) corresponding to an operating margin of 6.6 percent (7.9). · Profit after tax decreased by 9 percent and amounted to SEK 142 million (156) and earnings per share before dilution

Consort Medical becomes part of the Recipharm Group

Recipharm announced on 4 February 2020 that the offer to acquire Consort Medical plc (“Consort”) (the “Offer”) had become unconditional in all respects and will remain open for acceptances for a further 14 days, until 18 February 2020.  For more information on the Offer, Recipharm refers to the press release published on 4 February 2020. As a result of the Offer being declared wholly unconditional, Consort’s 2,000 employees and 10 facilities across the UK, Italy and Germany will become part of the Recipharm Group. Commenting on the announcement, Thomas Eldered, CEO at Recipharm said: “

KESKO BOARD'S PROPOSALS TO THE ANNUAL GENERAL MEETING

Kesko Corporation's Board of Directors has decided to propose to the Annual General Meeting convened for 30 March 2020 that a dividend of €2.52 per share be paid for the year 2019, that a resolution be made on a share issue without payment (share split) and on an amendment to section 3 of the Company’s Articles of Association, that the Board be authorised to decide on the issuance of shares, that a Shareholders’ Nomination Board be established, and that the Board be authorised to decide on donations for charitable purposes. The Board proposes that the firm of authorised public accountants

SimCorp A/S – New Share buyback program

Company Announcement no. 2/2020 SimCorp A/S (“SimCorp”) has today initiated a share buyback program for up to EUR 10.0m, to be executed during the period from February 5, 2020 to July 31, 2020. The buyback program is being launched in accordance with the authorization granted by the shareholders at the Annual General Meeting on March 27, 2019 to repurchase up to 10% of the SimCorp’s share capital in the period until the next annual general meeting. The buyback program will be structured and carried out in compliance with the provisions of Regulation No. 596/2014 of the European

Outokumpu initiates a strategic review of business area Long Products

Outokumpu OyjPress releaseFebruary 5, 2020 at 9.05 am EETOutokumpu initiates a strategic review of business area Long Products Outokumpu has initiated a strategic review of business area Long Products as part of its process to determine optimal long-term business mix for the company. During the review, Outokumpu will investigate multiple options regarding the business area’s future including opportunities for consolidation within the stainless long products markets. The strategic review is expected to be finalized during 2020. In 2019, business area Long Products’ net sales

H&M’s nomination committee proposes that Karl-Johan Persson is elected as the new chairman of the board of H & M Hennes & Mauritz AB at the annual general meeting on 7 May 2020

As communicated last week, Stefan Persson has announced that he will not stand for re-election as chairman of H&M at this spring’s annual general meeting. The nomination committee has unanimously decided to propose Karl-Johan Persson as new chairman of the board of H&M at the annual general meeting on 7 May 2020. In addition, the nomination committee will propose the re-election of all the current AGM-elected board members apart from Stefan Persson. It is therefore proposed that Stina Bergfors, Anders Dahlvig, Danica Kragic Jensfelt, Lena Patriksson Keller, Christian Sievert, Erica Wiking

Hexagon Year-End Report 1 January - 31 December 2019

Fourth quarter 2019- Net sales increased by 2 per cent to 1,058.9 MEUR (1,043.0). Using fixed exchange rates and a comparable group structure (organic growth), net sales decreased by -2 per cent- Operating earnings (EBIT1) increased by 2 per cent to 277.0 MEUR (270.7)- Earnings before taxes, excluding non-recurring items, amounted to 271.1 MEUR (265.4)- Net earnings, excluding non-recurring items, amounted to 222.3 MEUR (217.6)- Earnings per share, excluding non-recurring items, amounted to 0.60 EUR (0.60)- Operating cash flow, excluding non-recurring items, decreased to 234.4

Year-end Report January - December 2019

Period October - DecemberPeriod January - DecemberOctober – December in brief · Net sales rose by 22 percent to SEK 12,830 (10,537) thousand. · Gross profit improved by 1,109 thousand to SEK 12,065 (10,956) thousand. · Operating profit before depreciation and amortization (EBITDA) totaled SEK 492 (2,954) thousand. · Operating earnings fell SEK 2,434 to a loss of SEK 522 (profit: 1,912) thousand. · Comprehensive income for the period declined by SEK 2,180 thousand to a loss of SEK 895 (profit: 1,285) thousand. · Comprehensive income per share, basic and diluted, totaled

Year-end report 2019 Bactiguard Holding AB

A strong development in fourth quarter earnings, combined with the licensing deal with Zimmer Biomet led to the highest full-year result in Bactiguard's history. The financial effects of both increased BIP sales and new license revenues clearly show that our growth strategy works.Fourth quarter (October-December 2019) · Revenues amounted to SEK 61.6 (42.1) million, an increase of 46% mainly driven by higher BIP sales but also higher license revenues from BD.  · BIP sales amounted to SEK 25.3 (14.4) million. The increase of 75% is essentially a result of positive development in China

Year-end report 2019

THE SUBSIDIARY QLIRO AB TO BE LISTED, CDON BEING PREPARED FOR DISTRIBUTION TO OWNERS AND NELLY IMPLEMENTS ACTION PLAN FOURTH QUARTER[1] · Net sales amounted to SEK 919.2 (1,047.0) million · The subsidiary Qliro AB (previously called Qliro Financial Services) increased its loan book by 39 percent and total operating income by 8 percent · CDON increased its external merchant sales by 75 percent · Nelly’s net sales decreased by 1 percent · The gross margin increased to 22.7 (23.6) percent · Operating profit before depreciation and amortization amounted to SEK -18.5 (

Year-end Report January-December 2019

A QUARTER PERVADED BY TRANSACTIONS AND STRONG ORDER BOOKINGSOctober–December 2019 ·Order bookings amounted to SEK 2,969 million (1,000) ·Income amounted to SEK 2,253 million (1,991) ·The operating loss amounted to SEK 97 million (profit 509) ·Cash flow from operating activities amounted to SEK 83 million (264). Cash flow was affected adversely by investments of SEK 157 million in the production of tenant-owner apartments and the Karlastaden project ·The loss for the period amounted to SEK 63 million (profit 572) ·The final settlement of the

Sedana Medical establishes sales organization in Benelux

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has set up its own direct sales organization in Benelux, in line with the strategy of being represented in several European markets in order to have well-established networks and reference ICUs in Europe when IsoConDa is approved. The establishment in Benelux means that Sedana Medical now has its own representation in ten European countries.“We are proud that we can now start building market presence for inhaled sedation also in Belgium and the Netherlands. This is fully in line with our strategy to

Kesko's financial statements release for the period 1 Jan. to 31 Dec. 2019: Growth strategy yields record result

FINANCIAL PERFORMANCE IN BRIEF, CONTINUING OPERATIONS:                                     · Group net sales in January-December totalled €10,720.3 million (€10,382.8 million), an increase of 1.4% in comparable terms, reported net sales grew by 3.3% · Comparable operating profit totalled €461.6 million (€428.5 million) · Operating profit totalled €447.8 million (€404.3 million) · Comparable return on capital employed was 9.6% (9.8%) · Comparable profit before tax totalled €370.7 million (€325.2 million) · Comparable earnings per share totalled €2.97 (€2.45) · The Board

Outokumpu Financial Statements Release 2019 – Significant reduction of net debt to EUR 1,155 million

Outokumpu OyjFinancial statements releaseFebruary 5, 2020 at 9.00 am EETOutokumpu Financial Statements Release 2019 – Significant reduction of net debt to EUR 1,155 million Highlights in the fourth quarter of 2019 · Stainless steel deliveries were 458,000 tonnes (534,000 tonnes)1. · Adjusted EBITDA was EUR 73 million (EUR 89 million). · EBITDA was EUR 90 million (EUR 92 million). · Operating cash flow was EUR 143 million (EUR 43 million). · Net debt was EUR 1,155 million (September 30, 2019: EUR 1,336 million). · Gearing was 45.1% (September 30, 2019: 51.4%).

Loomis full-year report January – December 2019

October – December 2019Revenue for the fourth quarter amounted to SEK 5,342 million (4,956). Real growth was 5 percent (8) and organic growth was 1 percent (3). Loomis operating income (EBITA)[1)] amounted to SEK 693 million (593) and the operating margin was 13.0 percent (12.0). Income before taxes amounted to SEK 552 million (515) and income after taxes was SEK 407 million (387). Earnings per share before and after dilution amounted to SEK 5.42 (5.14). Cash flow from operating activities[2)] amounted to SEK 325 million (856), equivalent to 48 percent (144) of operating

Vattenfall – year-end report 2019

Financial highlights, January-December 2019 · Net sales increased by 9% (7% excluding currency effects) to SEK 166,360 million (152,091) · Underlying operating profit increased by 26% to SEK 25,095 million (19,883) · Operating profit increased by 26% to SEK 22,141 million (17,619) · Profit for the period increased by 24% to SEK 14,861 million (12,007) · The Board of Directors proposes a dividend of SEK 7,245 million, corresponding to 55% of profit for the year attributable to the owner of the Parent Company    Financial highlights, October-December 2019 · Net sales

Reminder: Invitation to presentation of Orkla’s fourth quarter 2019 results, Thursday 6 February

Orkla will report its fourth quarter 2019 results on Thursday, 6 February 2020 at 7.00 a.m. CET. The quarterly report and the presentation material will be available at this time at www.orkla.com.The quarterly results will be presented at 8.00 a.m. at the Orkla House, Drammensveien 149, Oslo. The presentation and subsequent Q&A session will be held in English and may be viewed in a live webcast at www.orkla.com or followed by telephone. Dial-in details: +47 21 03 33 94. Pincode: 1661193. To attend the presentation in Oslo, please register in advance by sending an email to: info@orkla.

SimCorp reports revenue growth of 19% and EBIT margin of 28% for 2019

Company Announcement no. 1/2020 Q4 2019 highlights: · Reported Q4 2019 revenue of EUR 127.8m, EBIT of EUR 34.0m and EBIT margin of 26.6% were, as expected and in accordance with our guidance, lower than the particularly strong Q4 2018 reported revenue of EUR 129.1m, EBIT of EUR 50.8m and EBIT margin of 39.4%. · Five new SimCorp Dimension and one new SimCorp Gain license deals were signed in Q4 2019. Total order intake was EUR 34.6m, a decrease of EUR 26.3m compared with Q4 2018, due to a very large new order in Asia in Q4 last year, a decrease in order intake from Client-Driven

Strengthened margin and sharply reduced net debt

President and CEO Henrik Hjalmarsson comments on the fourth quarter and full-year of 2019.“As we now close the books for 2019, I can sum up a year that largely progressed in accordance with our plan given the market conditions. We delivered strong cash flows and a sharply reduced level of debt. This was all in line with our undertakings to continuously strengthen the balance sheet to be able to conduct new, value-generating acquisitions when the timing is right”. “In the fourth quarter of 2019, despite relatively weak market activity in Business Area North, we delivered an improved

Year-end report January-December 2019

This information is such that Inwido AB (publ) is obliged to publish in accordance with the EU market abuse regulation and the Swedish Securities Market Act. The information was submitted by the below contact persons for publication on 5 February 2020 at 7:45 a.m. CET. Strengthened margin and sharply reduced net debtFourth quarter of 2019 · Net sales amounted to SEK 1,813 million (1,864), representing a decrease of 3%. Organic growth was a negative 4%. · EBITA amounted to SEK 186 million and the EBITA margin was 10.3%. Excluding IFRS 16, EBITA amounted to SEK 183 million (215)

There are no items matching the current filter
There are no more items matching the current filter
Back to top